There were no significant differences in CXCL13 levels between IPAH and CTEPH patients (122 ± 127 pg/ml versus 118 ± 124 pg/ml; p = 0.858). This evidence concerns the gene CXCL13 and chronic thromboembolic pulmonary hypertension.